Category:Protein expression-specific medications

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

Drugs with a regulatory indication for effectiveness (or lack of efficacy) in the context of one or more measurable protein expression patterns (including the absence of a protein expression, e.g., triple-negative breast cancer). This also includes mismatch repair deficient (dMMR) indications.